Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

MRI-guided Stroke Treatment with Ultrahigh Field-Steerable Robotic Magnetic Catheter

Project description

Robotic stroke treatment using MRI guidance

Stroke is a leading cause of death and long-term disability in aging populations, particularly in Europe where it causes over a million cases annually and costs billions in healthcare. Supported by the Marie Skłodowska-Curie Actions programme, the MR-Strokebot project aims to develop an MRI-guided robotic platform for stroke treatment that performs endovascular thrombectomy directly inside the MRI scanner using ultra-high field magnetic actuation and real-time MRI-based catheter tracking. By combining highly steerable robotic catheter technology with image-guided control, the system is designed to speed up navigation to the clot and eliminate delays caused by transferring patients between hospital suites after diagnosis. By reducing treatment delays, the project could help reduce the enormous healthcare and societal burden of stroke.

Objective

Stroke is among the most common causes of death and disabilities in aging societies. With a yearly 1.12 million incidence causing about 440 thousand deaths and a €45 billion healthcare cost in Europe only, stroke is a major socioeconomic burden. Acute ischemic stroke (AIS), the most common type at 87%, results in sudden blood circulation loss, leading to tissue death in a specific brain area. The disability-free outcome of AIS is directly related to fast and efficient stroke treatment, also referred to by clinicians as “Time-is-Brain.” Unfortunately, state-of-the-art endovascular stroke diagnosis and therapies take an average of 6 hours (stroke)-onset-to-treatment. An average of 2 hours is spent moving the patient from the medical imaging suite to the angiography suite after the diagnosis and accessing the stroke location using traditional endovascular instruments with limited steerability.
Magnetic Resonance Imaging (MRI)-guided STROKE Treatment with ultrahigh field (UHF)-steerable RoBOTic magnetic catheter (MR-STROKEBOT) project aims to minimize the treatment time by developing a magnetically actuated on-demand robotic thrombectomy surgery platform operating in the MRI scanner. MR-Strokebot’s key technologies are MRI-powered UHF magnetic actuation for high steerability and an MR image-based catheter tracking method. Combining these two techniques in an MRI-guided robotic platform, the MR-Strokebot will reduce treatment time in two ways. First, it will save time by eliminating the post-diagnostic mobility of the patient by performing the surgery in an MRI scanner right after diagnosis. Second, it will increase the endovascular navigation speed by enhanced steerability and MRI-guided robotic control. By significantly reducing treatment time, the MR-Strokebot has the potential to revolutionize endovascular stroke treatment in clinics and ultimately reduce the socioeconomic burden of stroke.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

MIDDLE EAST TECHNICAL UNIVERSITY
Net EU contribution
€ 149 365,20
Address
DUMLUPINAR BULVARI 1
06800 Ankara
Türkiye
Region
Batı Anadolu Ankara Ankara
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (1)